Dr. Lteif is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
VA Pittsburgh Healthcare System - University Drive Campus
University Drive C
Pittsburgh, PA 15240Phone+1 866-482-7488Fax+1 412-360-6588
Summary
- Dr. Amale Lteif is an endocrinologist in Pittsburgh, PA and is affiliated with Veterans Affairs Medical Center (Pittsburgh). She received her medical degree from American University of Beirut Faculty of Medicine and has been in practice 20 years. She also speaks multiple languages, including Arabic. She specializes in diabetes, gonad disorders & reproductive, and thyroid and is experienced in diabetes mellitus, obesity and obesity-related disorders, lipid metabolism disorders, osteoporosis, and thyroid ultrasonography. She has more than 10 publications and over 500 citings.
Education & Training
- Indiana University School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2003
- Indiana University School of MedicineResidency, Internal Medicine, 1998 - 2001
- American University of Beirut Faculty of MedicineClass of 1997
Certifications & Licensure
- PA State Medical License 2023 - 2024
- IN State Medical License 2000 - 2023
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- VA NEPHRON-D: Diabetes iN Nephropathy Study Start of enrollment: 2008 Jul 01
Publications & Presentations
PubMed
- 219 citationsObesity, Insulin Resistance, and the Metabolic Syndrome Determinants of Endothelial Dysfunction in Whites and BlacksAmale Lteif, K. Han, Kieren J. Mather
Circulation. 2005-07-05 - 12 citationsInsulin resistance as a therapeutic target for improved endothelial function: metformin.Lori A. Brame, Subodh Verma, Todd J. Anderson, Amale Lteif, Kieren J. Mather
Current Drug Targets. Cardiovascular & Haematological Disorders. 2004-02-29 - 80 citationsEndothelin limits insulin action in obese/insulin-resistant humans.Amale Lteif, Prashant Vaishnava, Alain D. Baron, Kieren J. Mather
Diabetes. 2007-03-01
Professional Memberships
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: